Amneal Pharmaceuticals, Inc.

AMRX ·Healthcare, Drug Manufacturers - General
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017
Assets
Cash & Equivalents $74.2M
Accounts Receivable $351.4M
Inventory $284.0M
Total Current Assets $771.9M
Property, Plant & Equipment $486.8M
Goodwill $26.4M
Intangible Assets (Excl. Goodwill) $44.6M
Total Assets $1.34B
Liabilities
Accounts Payable $70.0M
Total Current Liabilities $296.9M
Long-Term Debt $1.36B
Total Liabilities $0
Stockholders' Equity
Retained Earnings $-382.8M
Total Stockholders' Equity $0
← Newer Page 2 of 2 Older →